Literature DB >> 1107226

Decontamination of gnotobiotic mice experimentally monoassociated with Candida albicans.

M Wagner, K K Srivastava.   

Abstract

Gnotobiotic AKR mice, experimentally monoassociated with Candida albicans, were successfully decontaminated by oral treatment with amphotericin B incorporated in the drinking water. Germfree mice first were swabbed orally with viable C. albicans and then were allowed to acclimatize for 4 weeks. The log10 of number of C. albicans per gram of organ (with luminal contents) was 7.9 and 7.7 in the stomach and cecum, respectively. Direct fecal smears, as well as impresssion smears of stomach and cecum mucosal surfaces, revealed yeastphase cells, many with germ tubes, but no hyphal forms. No illness or mortality was observed over this period. The mice then were given amphotericin B DISsolved in the drinking water and offered ad libitum. At levels of 0.1 and 0.2 mg/ml, the number of fecal C. albicans was decreased but not eliminated completely. However, 0.3 mg/ml was sufficient to decontaminate the mice completely and return them to the germfree state. Residual amphotericin B was detected in the feces of the mice only while they were receiving the 0.3 mg/ml dose level. These mice remained germfree until the termination of the experiment, 10 weeks after the antibiotic had been discontinued and replaced by plain drinking water.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1107226      PMCID: PMC415448          DOI: 10.1128/iai.12.6.1401-1404.1975

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

1.  Active immunization of mice against Candida albicans.

Authors:  S MOURAD; L FRIEDMAN
Journal:  Proc Soc Exp Biol Med       Date:  1961-03

2.  Oral administration of solubilized amphotericin B.

Authors:  H M KRAVETZ; V T ANDRIOLE; M A HUBER; J P UTZ
Journal:  N Engl J Med       Date:  1961-07-27       Impact factor: 91.245

3.  Some aspects of the absorption, distribution, and excretion of amphotericin B in man.

Authors:  D B LOURIA
Journal:  Antibiotic Med Clin Ther (New York)       Date:  1958-05

4.  Pathogenesis of Candida albicans infection following antibiotic therapy. II. Further studies of the effect of antibiotics on the in vitro growth of Candida albicans.

Authors:  M HUPPERT; J CAZIN
Journal:  J Bacteriol       Date:  1955-10       Impact factor: 3.490

5.  Intradermal test in ankylostomiasis.

Authors:  B G PRASAD; G B MATHUR
Journal:  Indian J Med Res       Date:  1962-01       Impact factor: 2.375

6.  Spontaneous leukemia in germfree AK mice.

Authors:  M Pollard; M Kajima; B A Teah
Journal:  Proc Soc Exp Biol Med       Date:  1965-10

7.  Systemic fungal infections complicating renal transplantation and immunosuppressive therapy. Clinical, microbiologic, neurologic and pathologic features.

Authors:  D Rifkind; T L Marchioro; S A Schneck; R B Hill
Journal:  Am J Med       Date:  1967-07       Impact factor: 4.965

Review 8.  Mechanisms by which antibiotics increase the incidence and severity of candidiasis and alter the immunological defenses.

Authors:  M S Seelig
Journal:  Bacteriol Rev       Date:  1966-06

9.  Influence of antibiotics or certain intestinal bacteria on orally administered Candida albicans in germ-free and conventional mice.

Authors:  J D Clark
Journal:  Infect Immun       Date:  1971-12       Impact factor: 3.441

10.  Growth and invasiveness of Candida albicans in the germ-free and conventional mouse after oral challenge.

Authors:  A W Phillips; E Balish
Journal:  Appl Microbiol       Date:  1966-09
View more
  3 in total

1.  Colonization of congenitally athymic, gnotobiotic mice by Candida albicans.

Authors:  E Balish; M J Balish; C A Salkowski; K W Lee; K F Bartizal
Journal:  Appl Environ Microbiol       Date:  1984-04       Impact factor: 4.792

2.  Effect of oral tetracycline, the microbial flora, and the athymic state on gastrointestinal colonization and infection of BALB/c mice with Candida albicans.

Authors:  P B Helstrom; E Balish
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

3.  Intestinal fungi contribute to development of alcoholic liver disease.

Authors:  An-Ming Yang; Tatsuo Inamine; Katrin Hochrath; Peng Chen; Lirui Wang; Cristina Llorente; Sena Bluemel; Phillipp Hartmann; Jun Xu; Yukinori Koyama; Tatiana Kisseleva; Manolito G Torralba; Kelvin Moncera; Karen Beeri; Chien-Sheng Chen; Kim Freese; Claus Hellerbrand; Serene Ml Lee; Hal M Hoffman; Wajahat Z Mehal; Guadalupe Garcia-Tsao; Ece A Mutlu; Ali Keshavarzian; Gordon D Brown; Samuel B Ho; Ramon Bataller; Peter Stärkel; Derrick E Fouts; Bernd Schnabl
Journal:  J Clin Invest       Date:  2017-05-22       Impact factor: 19.456

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.